Registration Dossier

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2022
Report date:
2022

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
(OECD, 1997, as corrected in 2020)
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
(potassiooxy)potassium; (sodiooxy)sodium; oxobarium; oxocalcium; oxomagnesium
EC Number:
926-771-1
Molecular formula:
Not available.
IUPAC Name:
(potassiooxy)potassium; (sodiooxy)sodium; oxobarium; oxocalcium; oxomagnesium
Test material form:
solid: fibres

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
Type and composition of metabolic activation system:
- source of S9 : lyophilized phenobarbital/beta-naphthoflavone induced rat liver S9 and cofactors mix (MutazymeTM)
- method of preparation of S9 mix: reconstituted with cold, sterile water by adding 20 mL to each vial to provide a 10% phenobarbital/beta-naphthoflavone induced rat liver S9 and cofactors mix
- concentration or volume of S9 mix and S9 in the final culture medium : 0.5 mL of S9 mix added to 0.4 mL of test concentration, 0.1 mL bacterial strain culture and 2mL of media.
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): the sterility of the S9-mix was repeated, in triplicate, on the day of each experiment, Quality control certificate for enzymic activity and metabolic capacity provided in report.
Test concentrations with justification for top dose:
1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate
Top dose was guideline limit dose
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: sterile distilled water
Insoluble in most common solvents used in Ames test, distilled water gave best dosable suspension.
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
N-ethyl-N-nitro-N-nitrosoguanidine
benzo(a)pyrene
other: 2-Aminoanthracene
Details on test system and experimental conditions:
NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments : 2

METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in medium; in agar (plate incorporation) - 1st experiment; preincubation - 2nd experiment

TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable: 20 minutes
- Exposure duration/duration of treatment: 48-72 hours
Rationale for test conditions:
Standard guideline conditions
Evaluation criteria:
The reverse mutation assay may be considered valid if the following criteria are met:
1. The vehicle control counts should be consistent with the laboratory’s historical control ranges
2. The positive control chemicals should induce increases in mean revertant numbers of ≥2-fold (in strains TA98, TA100 and WP2 uvrA) or ≥3-fold (in strains TA1535 or TA1537) the concurrent vehicle control values, confirming discrimination between different strains, and an active S-9 preparation.
3. Contamination or some other confounding effect should not adversely impact the strain or assay functioning or prevent endpoint determination.

A test article is considered to have provided a mutagenic response if the assay data are valid, and:
1. Treatments with the test article provide a concentration-related increase in revertant numbers at one or more concentrations in at least one strain with or without metabolic activation system
2. An increase in mean revertant colony numbers per plate is observed which is ≥2-fold (in strains TA98, TA100 and WP2 uvrA) or ≥3-fold (in strains TA1535 or TA1537) the concurrent vehicle control values
3. Any increase in revertant numbers is reproducible, where applicable.
Statistics:
Statistical significance was not included as part of the result evaluation

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
Experiment 1 (plate incorporation)
There was no visible reduction in the growth of the bacterial background lawn at any dose level, either in the presence or in the absence of S9-mix.
A test item precipitate (fibrous in appearance) was noted under an inverted microscope at and above 50 μg/plate and by eye from 500 μg/plate in both the presence and absence of S9-mix. The precipitate did not prevent the scoring of revertant colonies.
There were no biologically relevant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without S9-mix.

Experiment 2 Repeat (pre-incubation)
There was no visible reduction in the growth of the bacterial background lawn at any dose level, either in the presence or in the absence of S9-mix.
A test item precipitate (fibrous in appearance) was noted under an inverted microscope at and above 50 μg/plate and by eye from 500 μg/plate in both the presence and absence of S9-mix. The precipitate did not prevent the scoring of revertant colonies.
There were no biologically relevant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without S9-mix.

Applicant's summary and conclusion

Conclusions:
The substance was considered to be non-mutagenic.
Executive summary:

In a Reverse Mutation Assay ‘Ames Test’ using strains of Salmonella typhimurium and Escherichia coli (OECD TG 471) the test item B glass microfibre did not induce an increase in the frequency of revertant colonies that met the criteria for a positive result, either with or without metabolic activation (S9-mix). Under the conditions of this test B glass microfibre was considered to be non-mutagenic.